StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)

Close on Nov 18, 2026Market cap $24.84MP/E –Yield –

MIRA Pharmaceuticals EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

MIRA Pharmaceuticals's EPS for the twelve months ending Jun 30, 2026 was -$1.39. For fiscal 2025 it was -$1.35.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.35–
FY2024Dec 31, 2024-$0.51–
FY2023Dec 31, 2023-$0.85–
FY2022Dec 31, 2022-$0.53–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.03–
Q1 FY2026Mar 31, 2026-$0.03–
Q4 FY2025Dec 31, 2025-$0.15–
Q3 FY2025Sep 30, 2025-$1.18–
Q2 FY2025Jun 30, 2025-$0.09–
Q1 FY2025Mar 31, 2025-$0.11–
Q4 FY2024Dec 31, 2024-$0.14–
Q3 FY2024Sep 30, 2024-$0.14–
Q2 FY2024Jun 30, 2024-$0.11–
Q1 FY2024Mar 31, 2024-$0.15–
Q4 FY2023Dec 31, 2023-$0.23–
Q3 FY2023Sep 30, 2023-$0.35–
Q2 FY2023Jun 30, 2023-$0.13–
Q1 FY2023Mar 31, 2023-$0.13–
Q4 FY2022Dec 31, 2022-$0.06–
Q3 FY2022Sep 30, 2022-$0.19–
Q2 FY2022Jun 30, 2022-$0.25–

More MIRA Pharmaceuticals figures

See a number that looks wrong?